PEBC MCQ Practice Questions by Topic

Dosing, dilutions, alligation, IV flow rates, and compounding math.

Hypertension, atrial fibrillation, anticoagulation, ACS, and venous thromboembolism.

Antibiotic selection, UTI, pneumonia, HIV, endocarditis, and antimicrobial stewardship.

Type 2 stepwise therapy, insulin, hypoglycemia, A1C targets, and diabetes in pregnancy.

Depression, bipolar disorder, anxiety, ADHD, insomnia, and antipsychotic monitoring.

Asthma, COPD, inhaler selection and technique, allergic rhinitis, and smoking cessation.

GERD, H. pylori, peptic ulcer disease, constipation, nausea, diarrhea, and IBD.

Contraception, the estrogen contraindications, emergency contraception, menopause, and vaginitis.

Chronic kidney disease, acute kidney injury, renal drug dosing, nephrotoxins, and electrolytes.

Acne, eczema, rosacea, lice and scabies, counselling, and the refer-or-treat decision.

Migraine and headache, seizures, Parkinson's disease, and the key safety counselling.

Analgesic selection, safe opioid prescribing, neuropathic pain, palliative care, and naloxone.

Rheumatoid arthritis and DMARDs, gout, osteoarthritis, and osteoporosis.

Weight-based dosing, fever, the drugs to avoid in children, and pediatric minor ailments.

Professional ethics, federal drug law, confidentiality, and the Canadian healthcare system.

Immunizations and injections, travel medicine, and health promotion.

The red eye, conjunctivitis, dry eye, glaucoma, and eye-drop counselling.

Erectile dysfunction, the PDE5 and nitrate rule, and benign prostatic hyperplasia.

Study design, relative and absolute risk, number needed to treat, and confidence intervals.

Half-life, steady state, therapeutic drug monitoring, and enzyme inducers and inhibitors.

The anemias, iron deficiency, B12 and folate, and VTE prophylaxis.

Chemotherapy side effects, nausea and vomiting, oncologic emergencies, supportive care, and staging.